DL
Dr Rohan Lalani
Alembic Pharmaceuticals (India), Sun Pharmaceutical Industries Limited, Maharaja Sayajirao University of Baroda, Lallubhai Motilal College of Pharmacy
0000-0001-8348-6795
Employment
-
Alembic Pharmaceuticals (India) Research Scientist
-
Sun Pharmaceutical Industries Limited Manager
Education
-
Maharaja Sayajirao University of Baroda PhD
-
Lallubhai Motilal College of Pharmacy M. Pharm
-
Indubhai Patel College of Pharmacy and Research Centre B. Pharm
Projects & Funding
Projects & funding information is unavailable.
Publications (14)
- An in vitro Assessment of Thermo-Reversible Gel Formulation Containing Sunitinib Nanoparticles for Neovascular Age-Related Macular Degeneration Save
- Combinatorial nanocarriers against drug resistance in hematological cancers: Opportunities and emerging strategies Save
- Lipid-nucleic acid nanoparticles of novel ionizable lipids for systemic BMP-9 gene delivery to bone-marrow mesenchymal stem cells for osteoinduction Save
- Surface engineered liposomal delivery of therapeutics across the blood brain barrier: recent advances, challenges and opportunities Save
- Antimicrobial peptide delivery: An emerging therapeutic for the treatment of burn and wounds Save
- Colloidally Stable Small Unilamellar Stearyl Amine Lipoplexes for Effective BMP-9 Gene Delivery to Stem Cells for Osteogenic Differentiation Save
- Hydroxyethyl substituted linear polyethylenimine for safe and efficient delivery of siRNA therapeutics Save
- Lipid-Based Oral Formulation Strategies for Lipophilic Drugs Save
- Liposomes encapsulating native and cyclodextrin enclosed paclitaxel: Enhanced loading efficiency and its pharmacokinetic evaluation Save
- Challenges in dermal delivery of therapeutic antimicrobial protein and peptides Save